Taconic Biosciences Hosts Symposia Series On Advanced Preclinical Models For Immuno-Oncology And Infectious Disease
Hudson, New York, USA, March 10, 2016 / B3C newswire / -- Taconic Biosciences, a leading provider of genetically modified solutions to researchers worldwide, will host a five-city symposia series in Europe on Advanced Preclinical Models for Immuno-Oncology and Infectious Disease. Scheduled for 30 March 30 – 5 April, this program will highlight the power and application of the most advanced, predictive models designed to address today’s most pressing research challenges in oncology, immuno-oncology, and infectious disease.
Industry-leading scientists from Taconic, together with Dr. Patrick Nef of Transcure bioServices, Dr. Valérie Soulard, Université Pierre et Marie CURIE (UPMC) and other speakers from renowned research organizations, will present methodologies to generate preclinical models with greater predictability of clinical outcomes, including human immune system engrafted NOG mice that can enhance the efficacy and safety testing of novel therapies. Application of these tools to immunotherapy studies will be discussed.
Topics will include:
• How human immune system engrafted mice are generated and applied
• How to choose the most appropriate xenograft host
• The engraftment procedure, donor-to-donor variability and immune cell lineage commitment in human immune system engrafted mice
• How to improve pre-clinical candidate selection using reconstitution of the human immune system as applied to infectious disease and inflammatory bowel disease
• How super immune-deficient mouse strains use can reduce animal usage, saving time and money To Find out more visit: http://info.taconic.com/eu-spring.
The Taconic symposia series schedule is as follows:
• Malmö, Sweden, 30 March – Medeon Science Park
• Oslo, Norway, 31 March – Oslo Cancer Cluster Incubator
• Paris, France, 1 April – Meliá Paris La Défense
• Leiden, Netherlands, 4 April – Hampshire Hotel - Fitland Leiden
• Munich, Germany, 5 April – IZB
To register, visit http://info.taconic.com/eu-spring.
About Taconic Biosciences, Inc.
Taconic Biosciences is a global provider of genetically engineered rodent models and services. Founded in 1952, Taconic helps the biotechnology and pharmaceutical communities acquire, custom generate, breed, precondition, test, and distribute highly relevant research models worldwide. Specialists in genetically engineered mouse and rat models, integrated model design and breeding services, and precision research mouse models, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe and maintains distributor relationships in Asia.
Industry-leading scientists from Taconic, together with Dr. Patrick Nef of Transcure bioServices, Dr. Valérie Soulard, Université Pierre et Marie CURIE (UPMC) and other speakers from renowned research organizations, will present methodologies to generate preclinical models with greater predictability of clinical outcomes, including human immune system engrafted NOG mice that can enhance the efficacy and safety testing of novel therapies. Application of these tools to immunotherapy studies will be discussed.
Topics will include:
• How human immune system engrafted mice are generated and applied
• How to choose the most appropriate xenograft host
• The engraftment procedure, donor-to-donor variability and immune cell lineage commitment in human immune system engrafted mice
• How to improve pre-clinical candidate selection using reconstitution of the human immune system as applied to infectious disease and inflammatory bowel disease
• How super immune-deficient mouse strains use can reduce animal usage, saving time and money To Find out more visit: http://info.taconic.com/eu-spring.
The Taconic symposia series schedule is as follows:
• Malmö, Sweden, 30 March – Medeon Science Park
• Oslo, Norway, 31 March – Oslo Cancer Cluster Incubator
• Paris, France, 1 April – Meliá Paris La Défense
• Leiden, Netherlands, 4 April – Hampshire Hotel - Fitland Leiden
• Munich, Germany, 5 April – IZB
To register, visit http://info.taconic.com/eu-spring.
About Taconic Biosciences, Inc.
Taconic Biosciences is a global provider of genetically engineered rodent models and services. Founded in 1952, Taconic helps the biotechnology and pharmaceutical communities acquire, custom generate, breed, precondition, test, and distribute highly relevant research models worldwide. Specialists in genetically engineered mouse and rat models, integrated model design and breeding services, and precision research mouse models, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe and maintains distributor relationships in Asia.